STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
GKOS GLAUKOS CORPORATION StockScouter® Report
4
StockScouter® Score
GLAUKOS CORPORATION, a mid cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly less than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- One or more less experienced analysts has modestly increased quarterly earnings estimates for GKOS. Positive/Neutral
- Shares are under accumulation by financial institutions. Marginally positive for large companies like GKOS
Concerns
- The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
- Earnings growth in the past year has decelerated moderately compared to earnings growth in the past three years. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be out of favor, growth stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
C
D
F
D